1 676 82 EFFECT OF A STRUCTURED YOGA PROGRAM ON FATIGUE, DEPRESSION, CARDIORESPIRATORY FITNESS, AND QUALITY OF LIFE IN A POSTMENOPAUSAL BREAST CANCER SURVIVOR. A 52-YEAR-OLD POSTMENOPAUSAL FEMALE DIAGNOSED WITH DUCT CARCINOMA OF THE LEFT BREAST UNDERWENT MODIFIED RADICAL MASTECTOMY 2 YEARS AGO. SHE HAD COMPLETED SIX CYCLES OF CHEMOTHERAPY POSTSURGERY AND COMPLAINED OF SIGNIFICANT FATIGUE AND DEPRESSION. HER FATIGUE SCORE ON PIPER FATIGUE SCALE WAS 4.1 AND DEPRESSION SCORE ON BECK'S DEPRESSION INVENTORY WAS 22. SHE HAD A POOR 6-MIN WALKING DISTANCE AND A REDUCED QUALITY OF LIFE. SHE WAS GIVEN A STRUCTURED YOGA PROGRAM FOR 40 MIN FIVE TIMES A WEEK FOR 4 WEEKS. RESULTS SHOWED A MARKED REDUCTION IN FATIGUE AND DEPRESSION SCORES AND IMPROVEMENT IN CARDIORESPIRATORY FITNESS. HER QUALITY OF LIFE ALSO SHOWED IMPROVEMENT AFTER THE STRUCTURED YOGA THERAPY. THIS CASE REPORT HIGHLIGHTS THE BENEFITS OF YOGA FOR REDUCING FATIGUE, DEPRESSION, AND IMPROVING THE CARDIORESPIRATORY FITNESS AND OVERALL QUALITY OF LIFE IN A BREAST CANCER SURVIVOR. 2018 2 2896 26 [EFFECT OF YOGA ON CANCER RELATED FATIGUE IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY]. OBJECTIVE: TO EVALUATE THE CONDITION OF CANCER-RELATED FATIGUE (CRF) IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY AND TO EXPLORE THE EFFECT OF YOGA ON IT. METHODS: AFTER THE COMPLETION OF YOGA, 100 BREAST CANCER PATIENTS WITH CRF (CFS>0) WERE SELECTED AND WERE RANDOMLY DIVIDED INTO THE YOGA GROUP AND THE CONTROL GROUP (N=50). PATIENTS IN THE CONTROL GROUP ONLY RECEIVED ROUTINE CURE AND CARE WHILE PATIENTS IN THE YOGA GROUP RECEIVED EXTRA YOGA EXERCISE, LASTING FOR 4 MONTHS. CANCER FATIGUE SCALE (CFS) WAS EVALUATED IN THE 2ND, 4TH AND 6TH ROUND OF CHEMOTHERAPY. RESULTS: AT THE END, 82 CASES QUALIFIED FOR THE STUDY, 42 CASES FOR THE CONTROL GROUP AND 40 FOR THE YOGA GROUP. THE MEAN SCORE OF BODY FATIGUE WAS 12.67+/-3.46. THERE WAS NO SIGNIFICANT DIFFERENCE IN CRF BETWEEN THE YAGO GROUP AND THE CONTROL GROUP BEFORE THE YOGA INTERVENTION (P>0.05). AFTER THE 4TH ROUND OF CHEMOTHERAPY, THE MEAN SCORES OF CFS AND BODY FATIGUE IN THE YOGA GROUP WERE SIGNIFICANTLY LOWER THAN THAT IN THE CONTROL GROUP (P<0.05). AFTER THE 6TH ROUND OF CHEMOTHERAPY, THE MEAN SCORES OF CFS, BODY FATIGUE AND COGNITIVE FATIGUE IN THE YOGA GROUP WERE LOWER THAN THAT IN THE CONTROL GROUP (P<0.05). REPEATED ANALYSIS OF VARIANCE SHOWED THAT THE DIFFERENCE IN THE OVERALL FATIGUE, BODY FATIGUE AND COGNITIVE FATIGUE BETWEEN THE YOGA GROUP AND THE CONTROL GROUP WAS SIGNIFICANT (P<0.05); THE TIME INFLUENCE ON THE OVERALL FATIGUE, BODY FATIGUE AND EMOTIONAL FATIGUE WAS SIGNIFICANT DIFFERENCE BETWEEN THE 2 GROUPS (P<0.05); THERE WERE INTERACTIONS BETWEEN THE EFFECT OF YAGO AND TIME ON THE OVERALL FATIGUE, BODY FATIGUE AND COGNITIVE FATIGUE (P<0.05). CONCLUSION: THE BODY FATIGUE WAS MORE SERIOUS IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY. YOGA INTERVENTION COULD SIGNIFICANTLY REDUCE BODY FATIGUE, COGNITIVE FATIGUE, THUS REDUCE THE OVERALL FATIGUE IN BREAST CANCER PATIENTS WITH CHEMOTHERAPY. 2014 3 97 20 A NONRANDOMIZED COMPARISON STUDY OF SELF-HYPNOSIS, YOGA, AND COGNITIVE-BEHAVIORAL THERAPY TO REDUCE EMOTIONAL DISTRESS IN BREAST CANCER PATIENTS. THE AUTHORS ASKED BREAST CANCER (BC) PATIENTS TO PARTICIPATE IN 1 OF 3 MIND-BODY INTERVENTIONS (COGNITIVE-BEHAVIORAL THERAPY (CBT), YOGA, OR SELF-HYPNOSIS) TO EXPLORE THEIR FEASIBILITY, EASE OF COMPLIANCE, AND IMPACT ON THE PARTICIPANTS' DISTRESS, QUALITY OF LIFE (QOL), SLEEP, AND MENTAL ADJUSTMENT. NINETY-NINE PATIENTS COMPLETED AN INTERVENTION (CBT: N = 10; YOGA: N = 21; AND SELF-HYPNOSIS: N = 68). RESULTS SHOWED HIGH FEASIBILITY AND HIGH COMPLIANCE. AFTER THE INTERVENTIONS, THERE WAS NO SIGNIFICANT EFFECT IN THE CBT GROUP BUT SIGNIFICANT POSITIVE EFFECTS ON DISTRESS IN THE YOGA AND SELF-HYPNOSIS GROUPS, AND, ALSO, ON QOL, SLEEP, AND MENTAL ADJUSTMENT IN THE SELF-HYPNOSIS GROUP. IN CONCLUSION, MIND-BODY INTERVENTIONS CAN DECREASE DISTRESS IN BC PATIENTS, BUT RCTS ARE NEEDED TO CONFIRM THESE FINDINGS. 2017 4 657 20 EFFECT OF 'EXERCISE WITHOUT MOVEMENT' YOGA METHOD ON MINDFULNESS, ANXIETY AND DEPRESSION. OBJECTIVE: TO ANALYZE THE EFFECT OF THE 'EXERCISE WITHOUT MOVEMENT' (E.W.M) YOGA METHOD ON MINDFULNESS AND ON THE IMPROVEMENT OF ANXIETY AND DEPRESSION SYMPTOMS. METHODS: A QUASI-EXPERIMENTAL STUDY EXAMINED THE EFFECT OF ONE MONTH E.W.M. INTERVENTION AMONG 38 PARTICIPANTS WHO WERE ENROLLED VOLUNTARILY TO BOTH GROUPS, STUDY (N = 16) AND CONTROL (N = 22). FIVE PARTICIPANTS DROPPED OUT DURING THE STUDY. THE STATE MINDFULNESS SCALE (SMS) WAS USED TO MEASURE MINDFULNESS. THE ANXIETY INVENTORY BECK (BAI) AND THE BECK DEPRESSION INVENTORY (BDI-II) WERE USED TO MEASURE THE ANXIETY AND DEPRESSION SYMPTOMS, RESPECTIVELY, BEFORE AND AFTER THE INTERVENTION. RESULTS: STUDY GROUP SHOWED BOTH A STATISTICALLY SIGNIFICANT INCREASE IN MINDFULNESS AND DECREASE IN ANXIETY AND DEPRESSION SYMPTOMS, COMPARED WITH THE CONTROL GROUP. CONCLUSIONS: THE E.W.M. HAS BEEN USEFUL IN THE DEVELOPMENT OF MINDFULNESS AND IN THE TREATMENT OF ANXIETY AND DEPRESSION SYMPTOMS AND MAY REPRESENT A NEW METHOD IN THE MINDFULNESS-BASED THERAPEUTIC APPLICATION. 2016 5 665 22 EFFECT OF A 10-WEEK YOGA PROGRAMME ON THE QUALITY OF LIFE OF WOMEN AFTER BREAST CANCER SURGERY. AIM OF THE STUDY: THE FOLLOWING RESEARCH IS AIMED AT DETERMINING THE EFFECT OF YOGA ON THE QUALITY OF LIFE OF WOMEN AFTER BREAST CANCER SURGERY. MATERIAL AND METHODS: A 10-WEEK YOGA PROGRAMME INCLUDED 90-MINUTE YOGA LESSONS ONCE A WEEK. TO ESTIMATE THE QUALITY OF LIFE, QUESTIONNAIRES DEVELOPED BY THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (QLQ-C30 AND QLQ-BR23) WERE USED. AN EXPERIMENTAL GROUP CONSISTED OF 12 WOMEN WHO PRACTISED YOGA, A CONTROL GROUP - OF 16 WOMEN WHO DID NOT. BETWEEN GROUPS THERE WERE NO DIFFERENCES IN AGE, TIME FROM OPERATION AND CHARACTERISTICS ASSOCIATED WITH DISEASE, TREATMENT AND PARTICIPATION IN REHABILITATION. RESULTS: OUR RESULTS REVEALED AN IMPROVEMENT OF GENERAL HEALTH AND QUALITY OF LIFE, PHYSICAL AND SOCIAL FUNCTIONING AS WELL AS A REDUCTION OF DIFFICULTIES IN DAILY ACTIVITIES AMONG EXERCISING WOMEN. ALSO THEIR FUTURE PROSPECTS ENHANCED - THEY WORRIED LESS ABOUT THEIR HEALTH THAN THEY USED TO BEFORE PARTICIPATING IN THE PROGRAMME. AS COMPARED TO BASELINE, AMONG EXERCISING WOMEN, FATIGUE, DYSPNOEA AND DISCOMFORT (PAIN, SWELLING, SENSITIVITY) IN THE ARM AND BREAST ON THE OPERATED SIDE DECREASED. CONCLUSIONS: PARTICIPATION IN THE EXERCISING PROGRAMME RESULTED IN AN IMPROVEMENT OF PHYSICAL FUNCTIONING, REDUCTION OF FATIGUE, DYSPNOEA, AND DISCOMFORT IN THE AREA OF THE BREAST AND ARM ON THE OPERATED SIDE. BASED ON OUR RESULTS AND THOSE OBTAINED IN FOREIGN STUDIES, WE CONCLUDE THAT REHABILITATION WITH THE USE OF YOGA PRACTICE IMPROVES THE QUALITY OF LIFE OF THE PATIENTS AFTER BREAST CANCER SURGERY. HOWEVER, WE RECOMMEND FURTHER RESEARCH ON THIS ISSUE IN POLAND. 2014 6 1085 22 EFFECTS OF YOGA ON STRESS, FATIGUE, MUSCULOSKELETAL PAIN, AND THE QUALITY OF LIFE AMONG EMPLOYEES OF DIAMOND INDUSTRY: A NEW APPROACH IN EMPLOYEE WELLNESS. BACKGROUND: DIAMOND INDUSTRY EMPLOYEES OFTEN EXPERIENCE MUSCULOSKELETAL PAIN, FATIGUE, AND STRESS, CONTRIBUTING TO A LOW QUALITY OF LIFE (QOL). YOGA IS AN ANCIENT DISCIPLINE OF MIND-BODY PRACTICE YOGA HAS NUMEROUS HEALTH BENEFITS. OBJECTIVE: THIS STUDY INVESTIGATED THE EFFICACY OF WORKPLACE YOGA IN IMPROVING STRESS, MUSCULOSKELETAL PAIN, FATIGUE, AND QOL AMONG EMPLOYEES OF THE DIAMOND INDUSTRY. METHODS: ONE-HUNDRED SIXTY-SIX EMPLOYEES OF THE DIAMOND INDUSTRY BETWEEN THE AGES OF 20 AND 60 PARTICIPATED IN THE STUDY. PARTICIPANTS WERE ASSIGNED TO EITHER YOGA (N = 84) OR WAITLIST (N = 82) GROUPS. THE YOGA GROUP RECEIVED ONE HOUR OF YOGA, FOUR DAYS A WEEK FOR THREE CONSECUTIVE MONTHS. PARTICIPANTS IN THE WAITLIST GROUP FOLLOWED THEIR DAILY ROUTINES. MUSCULOSKELETAL PAIN, FATIGUE, STRESS, AND QOL WERE ASSESSED AT BASELINE AND AFTER THREE MONTHS. RESULTS: ONE-HUNDRED FIFTY-FIVE EMPLOYEES COMPLETED THE STUDY. THE YOGA GROUP SHOWED SIGNIFICANT (P < 0.05) IMPROVEMENT IN PAIN, PERCEIVED STRESS, FATIGUE, AND QOL DOMAINS AFTER THREE MONTHS COMPARED TO BASELINE. THE WAITLIST GROUP SHOWED NO SIGNIFICANT IMPROVEMENT IN ANY OF THE MEASURES. IN THE POST SCORES COMPARISON BETWEEN THE GROUPS REVEALED A SIGNIFICANT DIFFERENCE BETWEEN THE GROUPS. CONCLUSION: WORKPLACE YOGA FOUND TO BE A USEFUL, COST-EFFECTIVE AND FEASIBLE INTERVENTION IN IMPROVING STRESS, MUSCULOSKELETAL PAIN, FATIGUES AND QUALITY OF LIFE AMONG EMPLOYEES OF THE DIAMOND INDUSTRY. YOGA MAY BE IMPLEMENTED IN THE WORKPLACE AS A WELLNESS PROGRAM AT THE WORKPLACE. 2021 7 123 29 A PILOT STUDY OF YOGA FOR BREAST CANCER SURVIVORS: PHYSICAL AND PSYCHOLOGICAL BENEFITS. BACKGROUND: PHYSICAL ACTIVITY PROVIDES A NUMBER OF PHYSICAL AND PSYCHOLOGICAL BENEFITS TO CANCER SURVIVORS, INCLUDING LESSENING THE IMPACT OF DETRIMENTAL CANCER-RELATED SYMPTOMS AND TREATMENT SIDE-EFFECTS (E.G. FATIGUE, NAUSEA), AND IMPROVING OVERALL WELL-BEING AND QUALITY OF LIFE. THE PURPOSE OF THE PRESENT PILOT STUDY WAS TO EXAMINE THE PHYSICAL AND PSYCHOLOGICAL BENEFITS AFFORDED BY A 7-WEEK YOGA PROGRAM FOR CANCER SURVIVORS. METHOD: ELIGIBLE PARTICIPANTS (PER-SCREENED WITH PAR-Q/PAR-MED-X) WERE RANDOMLY ASSIGNED TO EITHER THE INTERVENTION (N=20) OR CONTROL GROUP (N=18). ALL PARTICIPANTS COMPLETED PRE- AND POST-TESTING ASSESSMENTS IMMEDIATELY BEFORE AND AFTER THE YOGA PROGRAM, RESPECTIVELY. RESULTS: THE YOGA PROGRAM PARTICIPANTS (M AGE=51.18 (10.33); 92% FEMALE) INCLUDED PRIMARILY BREAST CANCER SURVIVORS, ON AVERAGE 55.95 (54.39) MONTHS POST-DIAGNOSIS. SIGNIFICANT DIFFERENCES BETWEEN THE INTERVENTION AND THE CONTROL GROUP AT POST-INTERVENTION WERE SEEN ONLY IN PSYCHOSOCIAL (I.E. GLOBAL QUALITY OF LIFE, EMOTIONAL FUNCTION, AND DIARRHEA) VARIABLES (ALL P'S <0.05). THERE WERE ALSO TRENDS FOR GROUP DIFFERENCES, IN THE HYPOTHESIZED DIRECTIONS, FOR THE PSYCHOSOCIAL VARIABLES OF EMOTIONAL IRRITABILITY, GASTROINTESTINAL SYMPTOMS, COGNITIVE DISORGANIZATION, MOOD DISTURBANCE, TENSION, DEPRESSION, AND CONFUSION (ALL P'S <0.10). FINALLY, THERE WERE ALSO SIGNIFICANT IMPROVEMENTS IN BOTH THE PROGRAM PARTICIPANTS AND THE CONTROLS FROM PRE- TO POST-INTERVENTION ON A NUMBER OF PHYSICAL FITNESS VARIABLES. CONCLUSIONS: THESE INITIAL FINDINGS SUGGEST THAT YOGA HAS SIGNIFICANT POTENTIAL AND SHOULD BE FURTHER EXPLORED AS A BENEFICIAL PHYSICAL ACTIVITY OPTION FOR CANCER SURVIVORS. FUTURE RESEARCH MIGHT ATTEMPT TO INCLUDE A BROADER RANGE OF PARTICIPANTS (E.G. OTHER TYPES OF CANCER DIAGNOSES, MALE SUBJECTS), A LARGER SAMPLE SIZE, AND A LONGER PROGRAM DURATION IN AN RCT. 2006 8 2112 20 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 9 1564 33 LONGITUDINAL IMPACT OF YOGA ON CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT AND QUALITY OF LIFE IN WOMEN WITH EARLY STAGE BREAST CANCER: A CASE SERIES. PURPOSE: ADJUVANT CHEMOTHERAPY FOR WOMEN WITH BREAST CANCER HAS SIGNIFICANTLY IMPROVED THE CURE RATE; HOWEVER, IT HAS BEEN ASSOCIATED WITH CHEMOTHERAPY-RELATED COGNITIVE IMPACT (CRCI). THE LITERATURE PROVIDES PRELIMINARY SUPPORT FOR THE FEASIBILITY AND EFFICACY OF YOGA INTERVENTIONS FOR THE GENERAL CANCER POPULATION, HOWEVER, CONTROLLED TRIALS ARE SCARCE AND NO STUDIES HAVE EXAMINED THE EFFECT OF YOGA ON COGNITION FOR WOMEN WITH BREAST CANCER DURING CHEMOTHERAPY. THIS CASE SERIES AIMS TO IDENTIFY THE IMPACT OF YOGA ON MEASURES OF COGNITION, FUNCTIONAL OUTCOMES, AND QUALITY OF LIFE (QOL) FOR BREAST CANCER SURVIVORS (BCS). METHODS: FOUR WOMEN WITH A DIAGNOSIS OF EARLY-STAGE BREAST CANCER PRIOR TO CHEMOTHERAPY TREATMENT WERE ADMINISTERED THE FOLLOWING PHYSIOLOGIC MEASURES AT BASELINE, 6, AND 12 WEEKS DURING CHEMOTHERAPY, AND AT ONE AND THREE MONTHS AFTER THE CONCLUSION OF THE STUDY: FUNCTIONAL REACH TEST (BALANCE) AND SIT AND REACH TEST (FLEXIBILITY), AND QOL, POMS (MOOD) AND FACT-B (QOL), AT BASELINE. PRIMARY OUTCOMES OF COGNITION WERE MEASURED WITH THE PERCEIVED COGNITION QUESTIONNAIRE (PCQ) AND COGSTATE, A COMPUTERIZED MEASUREMENT OF COGNITION. WOMEN ATTENDED AN IYENGAR-INSPIRED YOGA PROGRAM TWICE A WEEK FOR 12 WEEKS. QUALITATIVE QUESTIONNAIRES WERE ADMINISTERED AFTER THE COMPLETION OF THE STUDY TO DETERMINE PERCEIVED BENEFITS AND CHALLENGES OF THE YOGA PROGRAM. RESULTS: FOUR WOMEN WITH STAGE II BREAST CANCER RANGED IN AGE FROM 44-65 YEARS. COGSTATE COMPUTERIZED TESTING SHOWED CHANGES IN VARYING DOMAINS OF COGNITION THROUGH TREATMENT AND FOLLOW-UP. IMPROVED BALANCE, FLEXIBILITY, AND QOL WERE ALSO NOTED OVER TIME. NO ADVERSE EVENTS WERE OBSERVED. ANALYSIS OF QUALITATIVE DATA REVEALED THE YOGA CLASSES WERE HELPFUL AND SUBJECTS CONTINUED THE PRACTICE ELEMENTS OF YOGA INCLUDING RELAXATION, BREATHING, AND STRETCHING. THE MOST CHALLENGING ASPECT OF THE STUDY WAS PHYSICAL LIMITATIONS DUE TO VARIOUS MEDICAL COMPLICATIONS AND INCLUDED FATIGUE, DECREASED RANGE OF MOTION, AND PAIN. CONCLUSION: THIS CASE SERIES SUGGESTS THAT YOGA MAY IMPACT VARIOUS ASPECTS OF COGNITION DURING AND AFTER CHEMOTHERAPY ADMINISTRATION AS NOTED THROUGH QUANTITATIVE MEASURES. WOMEN DESCRIBE YOGA AS IMPROVING VARIOUS DOMAINS OF QOL THROUGH THE TREATMENT TRAJECTORY. THIS MIND-BODY INTERVENTION MAY STAVE OFF CRCI; HOWEVER, FURTHER INVESTIGATION IS NEEDED FOR ADDITIONAL RANDOMIZED CONTROLLED TRIALS ON THE EFFECTS OF YOGA ON COGNITION FOR WOMEN WITH BREAST CANCER UNDERGOING ADJUVANT CHEMOTHERAPY TREATMENT. 2012 10 1380 19 IMPACT OF LONG TERM YOGA PRACTICE ON SLEEP QUALITY AND QUALITY OF LIFE IN THE ELDERLY. BACKGROUND: SLEEP DISTURBANCES AND DECLINE IN THE PHYSICAL FUNCTIONALITY ARE COMMON CONDITIONS ASSOCIATED WITH AGING. PHARMACOLOGICAL TREATMENT OF SLEEP DISTURBANCES CAN BE ASSOCIATED WITH VARIOUS ADVERSE EFFECTS. SHORT TERM TRIALS OF YOGA ON SLEEP HAVE SHOWN BENEFICIAL EFFECTS. OBJECTIVES: TO EVALUATE THE EFFECT OF LONG-TERM YOGA EXERCISES ON SLEEP QUALITY AND QUALITY OF LIFE (QOL) IN THE ELDERLY. MATERIALS AND METHODS: THIS WAS A CROSS-SECTIONAL STUDY IN WHICH DATA WERE COLLECTED FROM ELDERLY PEOPLE AGED 60 YEARS OR MORE LIVING IN NAGPUR CITY. WE EMPLOYED TWO TYPES OF SURVEY QUESTIONNAIRES: PITTSBURGH SLEEP QUALITY INDEX (PSQI) AND QOL LEIDEN-PADUA (LEIPAD) QUESTIONNAIRE. A TOTAL OF 65 ELDERLY MEN AND WOMEN WHO SIGNED AN INFORMED CONSENT AND COMPLETED QUESTIONNAIRES WERE INCLUDED IN THE STUDY. SLEEP QUALITY SCORE PSQI AND QOL (LEIPAD QUESTIONNAIRE) SCORE OF THE STUDY GROUP WERE EVALUATED AND COMPARED WITH THE CONTROL GROUP USING MANN-WHITNEY U TEST. RESULTS: TOTAL PSQI SCORE IN YOGA GROUP WAS LOWER THAN THAT OF THE CONTROL GROUP. ALSO VARIOUS QOL SCORES OF THE YOGA GROUPS WERE HIGHER THAN THE CONTROL GROUP. CONCLUSION: ADDITION OF REGULAR YOGA EXERCISES IN THE DAILY ROUTINE OF ELDERLY PEOPLE CAN HELP TO ACHIEVE GOOD SLEEP QUALITY AS WELL AS IMPROVE THE QOL. 2013 11 1091 24 EFFECTS OF YOGA ON THE QUALITY OF LIFE IN CANCER PATIENTS. OBJECTIVE: THIS STUDY SOUGHT TO INVESTIGATE THE EFFECTS OF YOGA ON THE QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER. DESIGN: TWENTY PATIENTS BETWEEN 30 AND 50 YEARS OF AGE PRESENTLY UNDER TREATMENT FOR BREAST CANCER WERE INCLUDED IN THE STUDY. THE PHYSICAL CHARACTERISTICS OF THE PATIENTS WERE RECORDED AND GENERAL PHYSIOTHERAPY ASSESSMENTS PERFORMED. EIGHT SESSIONS OF A YOGA PROGRAM INCLUDING WARMING AND BREATHING EXERCISES, ASANAS, RELAXATION IN SUPINE POSITION, AND MEDITATION WERE APPLIED TO PARTICIPANTS. MAIN OUTCOME MEASURES: THE PRE- AND POST-YOGA QUALITY OF LIFE ASSESSMENTS FOR THE PATIENTS WERE CONDUCTED USING THE NOTTINGHAM HEALTH PROFILE (NHP). PATIENTS' STRESS LEVELS WERE ASSESSED USING THE STAI-I AND STAI-II ANXIETY INVENTORY. THEIR SATISFACTION LEVELS ABOUT THE YOGA PROGRAM WAS EVALUATED USING THE VISUAL ANALOG SCALE (VAS). RESULTS: IT WAS FOUND THAT PATIENTS' QUALITY OF LIFE SCORES AFTER THE YOGA PROGRAM WERE BETTER THAN SCORES OBTAINED BEFORE THE YOGA PROGRAM (P < 0.05). AFTER SESSIONS, THERE WAS A STATISTICALLY SIGNIFICANT DECREASE IN THEIR STAI-I (MEASURING THE REACTIONS OF ANXIETY) SCORES AND STAI-II (MEASURING THE PERMANENCE OF ANXIETY) SCORES (P < 0.05). IT WAS FOUND OUT THAT THE SATISFACTION SCORE CONCERNING THE YOGA PROGRAM WAS CONSIDERABLY INCREASED AFTER THE YOGA PROGRAM (P < 0.05). CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA IS VALUABLE IN HELPING TO ACHIEVE RELAXATION AND DIMINISH STRESS, HELPS CANCER PATIENTS PERFORM DAILY AND ROUTINE ACTIVITIES, AND INCREASES THE QUALITY OF LIFE IN CANCER PATIENTS. THIS RESULT WAS POSITIVELY REFLECTED IN PATIENTS SATISFACTION WITH THE YOGA PROGRAM. 2010 12 2096 29 THE EFFECT OF YOGA EXERCISE ON IMPROVING DEPRESSION, ANXIETY, AND FATIGUE IN WOMEN WITH BREAST CANCER: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DEPRESSION, ANXIETY, AND FATIGUE ARE AMONG THE MOST SIGNIFICANT PROBLEMS THAT INFLUENCE THE QUALITY OF LIFE OF PATIENTS WITH BREAST CANCER WHO RECEIVE ADJUVANT CHEMOTHERAPY. ALTHOUGH EVIDENCE HAS SHOWN YOGA TO DECREASE ANXIETY, DEPRESSION, AND FATIGUE IN PATIENTS WITH CANCER, FEW STUDIES ON THE EFFECTS OF YOGA HAVE TARGETED PATIENTS WITH BREAST CANCER. YOGA INTERVENTIONS SHOULD BE TESTED TO PROMOTE THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER. PURPOSE: THIS STUDY EXAMINES THE EFFECTIVENESS OF AN 8-WEEK YOGA EXERCISE PROGRAM IN PROMOTING THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER UNDERGOING ADJUVANT CHEMOTHERAPY IN TERMS OF DEPRESSION, ANXIETY, AND FATIGUE. METHODS: A SAMPLE OF 60 WOMEN WITH NONMETASTATIC BREAST CANCER WAS RECRUITED. PARTICIPANTS WERE RANDOMLY ASSIGNED INTO EITHER THE EXPERIMENTAL GROUP (N = 30) OR THE CONTROL GROUP (N = 30). A 60-MINUTE, TWICE-PER-WEEK YOGA EXERCISE WAS IMPLEMENTED FOR 8 WEEKS AS THE INTERVENTION FOR THE PARTICIPANTS IN THE EXPERIMENTAL GROUP. THE CONTROL GROUP RECEIVED STANDARD CARE ONLY. RESULTS: ANALYSIS USING THE JOHNSON-NEYMAN PROCEDURE FOUND THAT THE YOGA EXERCISE REDUCED OVERALL FATIGUE AND THE INTERFERENCE OF FATIGUE IN EVERYDAY LIFE FOR THE EXPERIMENTAL GROUP PARTICIPANTS. SIGNIFICANT REDUCTIONS WERE OBTAINED AFTER 4 WEEKS OF INTERVENTION PARTICIPATION FOR THOSE EXPERIMENTAL GROUP PATIENTS WITH RELATIVELY LOW STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 3.31 AND 3.22, RESPECTIVELY) AND AFTER 8 WEEKS FOR MOST PATIENTS (APPROXIMATELY 75%) WITH MODERATE STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 7.30 AND 5.34, RESPECTIVELY). THE 8-WEEK INTERVENTION DID NOT SIGNIFICANTLY IMPROVE THE LEVELS OF DEPRESSION (F = 1.29, P > .05) OR ANXIETY (F = 2.7, P > .05). CONCLUSIONS/IMPLICATIONS FOR PRACTICE: THE 8-WEEK YOGA EXERCISE PROGRAM DEVELOPED IN THIS STUDY EFFECTIVELY REDUCED FATIGUE IN PATIENTS WITH BREAST CANCER BUT DID NOT REDUCE DEPRESSION OR ANXIETY. ONCOLOGY NURSES SHOULD STRENGTHEN THEIR CLINICAL HEALTH EDUCATION AND APPLY YOGA TO REDUCE THE FATIGUE EXPERIENCED BY PATIENTS WITH BREAST CANCER WHO UNDERGO ADJUVANT CHEMOTHERAPY. 2014 13 748 20 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 14 2221 16 THE IMPACT OF LAUGHTER YOGA ON THE STRESS OF CANCER PATIENTS BEFORE CHEMOTHERAPY. BACKGROUND: CANCER IS USUALLY ACCOMPANIED BY CONSIDERABLE STRESS FOR THE SUFFERER, AND THE STRESS HAS DESTRUCTIVE EFFECTS ON CHEMOTHERAPY TREATMENT PROCESS. THEREFORE, THE CURRENT RESEARCH DEALS WITH THE EFFECT OF YOGA LAUGHTER ON THE CANCER PATIENTS' STRESS BEFORE CHEMOTHERAPY. METHODS: IN THIS RESEARCH, AS THE FIRST STEP, 37 CANCER SUFFERERS , WHO HAD BEEN HOSPITALIZED IN SHOHADA TAJRISH HOSPITAL (BEHNAM DANESHPOOR CHARITY ORGANIZATION) AND HAD THE REQUIREMENTS NECESSARY FOR BEING TAKEN AS RESEARCH SAMPLES, WERE SELECTED FOR DATA COLLECTION. THE MENTIONED PATIENTS WERE CLASSIFIED RANDOMLY IN EXPERIMENTAL AND CONTROL GROUPS. COLLECTED DATA WERE ANALYZED BY THE MULTI-VARIABLE COVARIANCE ANALYSIS TEST. RESULTS: THE RESULTS SHOW THERE IS A MEANINGFUL DIFFERENCE IN THE STRESS AVERAGE BEFORE AND AFTER INTERFERENCE IN THE TEST GROUP (P<0.05). CONCLUSION: LAUGHTER YOGA CAN DECREASE THE STRESS IN CANCER SUFFERERS BEFORE CHEMOTHERAPY. 2014 15 728 25 EFFECT OF LONG-TERM YOGA PRACTICE ON PSYCHOLOGICAL OUTCOMES IN BREAST CANCER SURVIVORS. AIM: BREAST CANCER HAS BECOME A PANDEMIC WITH AN EVER-INCREASING INCIDENCE. ALTHOUGH BETTER DIAGNOSTICS AND TREATMENT MODALITIES HAVE REDUCED MORTALITY, A LARGE NUMBER OF SURVIVORS FACE CANCER AND TREATMENT-RELATED LONG-TERM SYMPTOMS. MANY SURVIVORS ARE TAKING UP YOGA FOR IMPROVING THE QUALITY OF LIFE (QOL). THE PRESENT STUDY ATTEMPTS TO EVALUATE PREDICTORS OF PSYCHOLOGICAL STATES IN BREAST CANCER SURVIVORS WITH LONG-TERM YOGA EXPERIENCE. MATERIALS AND METHODS: A CASE-CONTROL STUDY RECRUITED EARLY BREAST CANCER SURVIVORS, 30-65 YEARS, COMPLETING TREATMENT > 6 MONTHS BEFORE RECRUITMENT, AND GROUPED THEM BASED ON PRIOR YOGA EXPERIENCE (BCY, N = 27) OR NAIVE (BCN, N = 25). DEMOGRAPHY, CANCER HISTORY, DIET, EXERCISE HABITS, AND YOGA SCHEDULE WERE COLLECTED AND TOOLS TO ASSESS STRESS, ANXIETY, DEPRESSION, GENERAL HEALTH, AND QOL WERE ADMINISTERED. MULTIVARIATE LINEAR REGRESSION WAS DONE TO IDENTIFY PREDICTORS OF PSYCHOLOGICAL VARIABLES. RESULTS: BCY HAD SIGNIFICANTLY LOWER STRESS, ANXIETY, DEPRESSION, BETTER GENERAL HEALTH, AND QOL (P < 0.001). GLOBAL QOL AND TRAIT ANXIETY WERE SIGNIFICANTLY PREDICTED BY YOGA PRACTICE; DEPRESSION WAS PREDICTED BY YOGA PRACTICE, ANNUAL INCOME, AND SLEEP QUALITY; STATE ANXIETY WAS PREDICTED BY YOGA PRACTICE AND INCOME; AND STRESS WAS PREDICTED BY YOGA PRACTICE AND SLEEP QUALITY. CONCLUSION: RESULTS INDICATE THAT BREAST CANCER SURVIVORS, DOING YOGA, HAVE BETTER PSYCHOLOGICAL PROFILES AND ARE ABLE TO DEAL WITH DEMANDING SITUATIONS BETTER. THE PSYCHO-ONCOGENIC MODEL OF CANCER ETIOLOGY SUGGESTS THAT A BETTER PSYCHOLOGICAL STATE IN SURVIVAL HAS THE POTENTIAL TO IMPROVE PROGNOSIS AND SURVIVAL OUTCOMES AND YOGA MAY BE A SUITABLE PRACTICE FOR STAYING CANCER-FREE FOR A LONGER TIME. 2017 16 2673 21 YOGA IN PRIMARY HEALTH CARE: A QUASI-EXPERIMENTAL STUDY TO ACCESS THE EFFECTS ON QUALITY OF LIFE AND PSYCHOLOGICAL DISTRESS. BACKGROUND: AND PURPOSE: YOGA IS GROWING IN POPULARITY, BUT ITS BENEFITS AND INTEGRATION INTO PRIMARY CARE REMAIN UNCERTAIN. HERE, WE DETERMINE YOGA EFFECTS ON QUALITY OF LIFE AND PSYCHOLOGICAL DISTRESS, AND EVALUATE THE FEASIBILITY OF INTRODUCING YOGA AT PRIMARY CARE LEVEL. MATERIALS AND METHODS: THIS IS A PROSPECTIVE, LONGITUDINAL, QUASI-EXPERIMENTAL STUDY, WITH AN INTERVENTION (N=49) AND A CONTROL GROUP (N=37). YOGA GROUP UNDERWENT 24-WEEKS PROGRAM OF ONE-HOUR SESSIONS. OUR PRIMARY ENDPOINT WAS QUALITY OF LIFE AND PSYCHOLOGICAL DISTRESS, AS WELL AS SATISFACTION LEVEL AND ADHERENCE RATE. RESULTS: PARTICIPANTS REPORTED A SIGNIFICANT IMPROVEMENT IN ALL DOMAINS OF QUALITY OF LIFE AND A REDUCTION OF PSYCHOLOGICAL DISTRESS. LINEAR REGRESSION ANALYSIS SHOWED THAT YOGA SIGNIFICANTLY IMPROVES PSYCHOLOGICAL QUALITY OF LIFE (P=0.046). CONCLUSION: YOGA IN PRIMARY CARE IS FEASIBLE, SAFE AND HAS A SATISFACTORY ADHERENCE, AS WELL AS A POSITIVE EFFECT ON PSYCHOLOGICAL QUALITY OF LIFE OF PARTICIPANTS. 2019 17 2173 16 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 18 206 21 A SELF-DIRECTED HOME YOGA PROGRAMME FOR WOMEN WITH BREAST CANCER DURING CHEMOTHERAPY: A FEASIBILITY STUDY. RECENT STUDIES SUGGEST YOGA AS A PROMISING APPROACH FOR IMPROVING THE COGNITIVE FUNCTION OF CANCER SURVIVORS. WE STUDIED WHETHER A SELF-DIRECTED HOME YOGA PROGRAMME WAS FEASIBLE FOR PATIENTS WITH BREAST CANCER WHO WERE UNDERGOING CHEMOTHERAPY. PARTICIPANTS' PREFERENCES FOR THE TYPE OF YOGA COURSE AND THE CLINICAL EFFECTS OF THE PROGRAMME WERE ALSO ASSESSED. IN THIS STUDY, 18 WOMEN (MEAN AGE, 43.9 YEARS) WERE ENROLLED (44.7% RECRUITMENT RATE). OF THE PARTICIPANTS, 63.6% HAD STAGE II CANCER AND 71.4% RECEIVED ADJUVANT CHEMOTHERAPY. FAVOURABLE RETENTION (86%), ADHERENCE (94.4%) AND ACCEPTABILITY (96.5%) RATES WERE DETERMINED. MOST (94.4%) OF THE WOMEN PRACTICED THE HOME PROGRAMME MORE THAN TWICE A WEEK ON AVERAGE. THE PARTICIPANTS PREFERRED TO GRADUALLY INCREASE THE INTENSITY OF THE EXERCISES. WE ONLY OBSERVED IMPROVEMENTS IN THE COGNITIVE ASPECTS OF FATIGUE. NO SERIOUS ADVERSE EVENTS WERE ENCOUNTERED DURING THE PROGRAMME. THIS SELF-DIRECTED HOME YOGA PROGRAMME WAS SAFE AND FEASIBLE FOR PATIENTS WITH BREAST CANCER UNDERGOING CHEMOTHERAPY. 2016 19 1381 24 IMPACT OF NATUROPATHY, YOGA, AND DIETARY INTERVENTIONS AS ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF STAGE II AND III ADENOCARCINOMA OF THE COLON. INTRODUCTION: NATUROPATHY, YOGA AND DIETARY INTERVENTIONS ARE KNOWN TO IMPROVE THE QUALITY OF LIFE IN CANCER PATIENTS. WE AIM TO EVALUATE THE EFFECT OF NATUROPATHY INTERVENTIONS ALONG WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WHO UNDERWENT SURGERY FOR ADENOCARCINOMA OF THE COLON. METHODS: A TOTAL OF 116 ADULT PATIENTS WERE RANDOMISED IN TO ONE OF THE TWO GROUPS; THE EXPERIMENTAL GROUP RECEIVED NATUROPATHY, YOGA AND DIETARY INTERVENTIONS AND THE CONTROL GROUP RECEIVED PSYCHO-SOCIAL COUNSELLING IN ADDITION TO STANDARD CHEMOTHERAPY. HAEMATOLOGICAL, BIOCHEMICAL AND PSYCHOLOGICAL EVALUATIONS WERE PERFORMED AT SET INTERVALS DURING A TOTAL PERIOD OF EIGHTEEN MONTHS STARTING FROM THE FIRST CYCLE OF ADJUVANT CHEMOTHERAPY. RESULTS: RESULTS SHOWED THAT THE OVERALL HEMOGLOBIN (P < 0.0001) AND CARCINOEMBRYONIC ANTIGEN (CEA) (P = 0.0038) LEVELS WERE STATISTICALLY SIGNIFICANT IN PATIENTS ON THE EXPERIMENTAL ARM. THE REST OF THE LABORATORY PARAMETERS, VIZ. TOTAL LEUKOCYTE COUNT, PLATELET COUNTS, AND SERUM CREATININE LEVELS, FOR OVERALL DATA WAS NOT STATISTICALLY SIGNIFICANT IN BOTH THE GROUPS. PSYCHOLOGICAL ATTRIBUTES SUCH AS ANXIETY, DEPRESSION, SYMPTOM SEVERITY, AND FUNCTIONAL LIVING INDEX: CANCER (FLIC) WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.0001) IN THE EXPERIMENTAL SUBJECTS AS COMPARED WITH THOSE IN THE CONTROL. ON THE WHOLE, MEN BENEFITED MORE THAN WOMEN FROM THE STUDY INTERVENTIONS. CONCLUSIONS: WE CONCLUDE THAT YOGA AND NATUROPATHY INTERVENTIONS IN ADDITION TO CHEMOTHERAPY SHOW IMPROVEMENT IN OVERALL FUNCTIONAL LIFE INDEX ALONG WITH IMPROVEMENT IN HAEMOGLOBIN IN PATIENTS WITH STAGES II AND III ADENOCARCINOMA OF COLON. 2020 20 1818 23 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019